Mar 01, 2024
Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...
Read More...
May 09, 2022
Food allergies are becoming a global concern. According to the World Allergy Organization, "food allergy impacted around 2.5% of the general population, but prevalence figures ranged from 1% to 10%." The increasing incidence of food allergies is raising food safety and public health issues and it is estimated that ...
Read More...
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Newsletter/Whitepaper